Innovation Pharmaceuticals Inc.
IPIX · OTC
6/30/2023 | 6/30/2022 | 6/30/2021 | 6/30/2020 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $1,518 | $3,807 | $10,194 | $6,018 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $116 | $0 | $0 | $0 |
| Total Curr. Assets | $1,634 | $3,952 | $10,689 | $6,110 |
| Property Plant & Equip (Net) | $0 | $0 | $0 | $0 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $1,999 | $2,312 | $2,754 | $3,060 |
| Long-Term Investments | $3,806 | $3,978 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $78 | $137 | $856 | $78 |
| Total NC Assets | $5,883 | $6,427 | $3,610 | $3,138 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $7,517 | $10,379 | $14,299 | $9,248 |
| Liabilities | – | – | – | – |
| Payables | $1,499 | $1,081 | $1,077 | $557 |
| Short-Term Debt | $213 | $250 | $1,455 | $1,901 |
| Tax Payable | $147 | $148 | $207 | $198 |
| Deferred Revenue | $0 | $0 | $207 | $0 |
| Other Curr. Liab. | $1,491 | $1,548 | $1,294 | $1,697 |
| Total Curr. Liab. | $5,021 | $4,808 | $6,538 | $7,369 |
| LT Debt | $457 | $786 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $457 | $841 | $252 | $417 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $55 | $252 | $417 | $555 |
| Total Liabilities | $5,478 | $5,649 | $6,790 | $7,786 |
| Equity | – | – | – | – |
| Pref Stock | $5 | $0 | $15 | $13 |
| Common Stock | $52 | $51 | $44 | $33 |
| Retained Earnings | -$125,325 | -$122,157 | -$115,116 | -$101,244 |
| AOCI | -$5 | $0 | -$15 | -$13 |
| Other Equity | $0 | $0 | $0 | $0 |
| Total Equity | $2,039 | $4,730 | $7,509 | $1,462 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $7,517 | $10,379 | $14,299 | $9,248 |
| Net Debt | -$848 | -$2,771 | -$8,739 | -$4,117 |